The Effect of AposTherapy on Pain and Function in a Non Specific Low Back Pain (AposBack)
Primary Purpose
Low Back Pain
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
AposTherapy
Traditional Physical Therapy
Sponsored by
About this trial
This is an interventional treatment trial for Low Back Pain focused on measuring Oswestry, SF 36, Promis Pain and Function, Berg Balance
Eligibility Criteria
Inclusion Criteria:
•Patients suffering from symptomatic axial lower back pain for at least 24 weeks.
- Patients with VAS pain score of ≥3cm (measured at baseline).
- Males and females between the ages of 30-85.
- 17<BMI<40
- Ambulatory and active patients that can participate in a rehabilitation program that includes daily walking
- Stable medicine regimen (no recent changes to their pain medication within a month)
- Able to walk at least 50 meters and scored positive on the STEADI test (Supp. 1)
- Able to understand, read and sign the informed consent form
- English or Spanish speaking
Exclusion Criteria:
•Patients suffering from active inflammatory joint disease.
- Patients with diagnosis of neuromuscular disease.
- Patients with more than 3 falls in the last 52 weeks, OR any balance related fall with an injury in the last 52 weeks.
- Patients exhibiting a lack of physical or mental ability to perform or comply with the study procedure.
- Patients with a history of pathological osteoporotic fracture
- Patients with referred pain consistent with radicular etiology
- Patients with generalized body pain (both upper and lower extremities).
- No spine surgery within 24 weeks.
- No image guided lumbar intervention in the past 8 weeks.
- No major cardiovascular comorbidities (able to enroll in an active exercise program)
- Patient started on lipid lowering medication in last 12 weeks
- Any change in blood pressure medications
- No recent physical therapy for the back. (within the last 12 weeks)
- No active heart disease (ischemia or heart failure admissions within 24 weeks) and no active COPD (exacerbation within 24 weeks)
- No active malignancies on ongoing treatment
- Patient with neurological gait pattern.
- Patient requiring assistive device during gait analysis.
Sites / Locations
- Montefiore Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Traditional Physical Therapy
AposTherapy
Arm Description
Up to 20 sessions of traditional physical therapy.
Treatment with at home AposTherapy with daily use of the shoe.
Outcomes
Primary Outcome Measures
Function
Improvement in back pain measured and assessed with the Oswestry Disability Index (ODI).
Secondary Outcome Measures
PROMIS (Patient-Reported Outcomes Measurement Information System) Pain Interference and Physical Function
Pain and Function measured through PROMIS short forms
Pain medication consumption
medication consumption
Quality of life survey
Quality of life assessed with Short Form Health Survey questionnaire
Gait assessment
objective analysis of patients' gait assessed with a pressure mat to demonstrate stride length, velocity, and symmetry.
6-min walk test
objective assessment using maximum distance comfortably walked in 6 minutes on a 100 foot closed course
Dynamic balance
Measured by Berg balance test assessed with a questionnaire
Static balance
functional reach test assessed by physically testing the patient with a standardized set of instructions
Blood pressure
Change in blood pressure , physiological parameter
resting heart rate
change in resting heart rate , physiological parameter
Overall activity
overall activity measured as daily steps, through wristband devices
sleep patterns
Total sleep time measured in minutes through wristband activity monitor (FitBit) measured over one week
Visual Analog Scale (VAS) for pain measurement
questionnaire
Medication Consumption
Track increase or decrease in Medication consumption- assessed through patient interview and patent report
Medication Costs
Calculate monetary savings in Medication Costs- assessed through patient interview and prevailing market cost information
Hospitalization utilizations
Calculate the increase/decrease in hospital facility utilization - assessed with patient interview and health records.
Full Information
NCT ID
NCT03167671
First Posted
March 21, 2017
Last Updated
July 21, 2023
Sponsor
Montefiore Medical Center
Collaborators
Apos Medical and Sports Technology Ltd.
1. Study Identification
Unique Protocol Identification Number
NCT03167671
Brief Title
The Effect of AposTherapy on Pain and Function in a Non Specific Low Back Pain
Acronym
AposBack
Official Title
The Effect of AposTherapy on Pain and Function in a Non Specific Low Back Pain Population. A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
August 15, 2017 (Actual)
Primary Completion Date
January 28, 2024 (Anticipated)
Study Completion Date
January 28, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Montefiore Medical Center
Collaborators
Apos Medical and Sports Technology Ltd.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
AposTherapy is a home based exercise program utilizing footwear that causes exercise with normal activity that may significantly improve function in patients with back pain since patients with back pain have altered mechanics of motion contributing or due to the presence of the conditions. Capitalizing on the reported excellent adherence and clinical benefit of ApostTherapy in patients with significant knee and back pain, we propose to evaluate this as a conservative treatment that may supplant/supplement traditional pain medications and physical therapy in an at-risk urban inner city population.
Detailed Description
AposTherapy® is a home-based exercise program utilizing footwear that causes exercise with normal daily activity that may significantly improve function in patients with back pain in general, and specifically Axial Low Back Pain (NSLBP). Capitalizing on the reported excellent adherence and clinical benefit of Apos Therapy in patients with significant back pain, we propose to evaluate this as a conservative treatment that may supplant/supplement traditional pain medications and physical therapy in NSLBP population.
A possible potential use of AposTherapy® as a replacement for traditional physical therapy may yield a less costly, more effective therapy with better adherence. Problems with traditional therapy include poor patient adherence to both outpatient and home therapy programs, the added cost of travel (which may be more than $100 per session for ambulette or access-a-ride for eligible patients), and the lack of continuation in an ongoing exercise program[6-8], all of which can lead to relapse and need for retreatment. Additionally, access to physical therapy is limited for many patients since there are not enough available outpatient therapy services to meet the needs of all patients. Finding an alternative exercise program that will increase adherence, decrease total therapy visits, and improve patient's outcomes with decreased dependence on pain medications is a high priority from both patient care and cost management perspectives.
AposTherapy® potentially overcomes many of these issues by improving/modifying abnormal biomechanics (therefore decreasing pain), and providing an independent home-based exercise program utilizing footwear that causes exercise with normal activity by promoting perturbation. This biomechanical approach may significantly reduce pain and improve function in patients with nonspecific low back pain (NSLBP). Capitalizing on the reported excellent adherence and clinical benefit of AposTherapy® in patients with significant NSLBP, we propose to evaluate the biomechanical exercise (wearing an appropriately calibrated shoe at home for a prescribed amount of time each day) as a conservative treatment that may supplement or supplant traditional pain medications, interventional pain procedures and physical therapy in an at-risk urban inner city population with NSLBP.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain
Keywords
Oswestry, SF 36, Promis Pain and Function, Berg Balance
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Single blinded (evaluator), single-center, randomized controlled trial. Interventional and Control group with option for Control group to Cross over.
Masking
Outcomes Assessor
Masking Description
The outcomes assessor is the only one masked in the study. They are independent of the randomization, trial coordination, and care providers.
Allocation
Randomized
Enrollment
143 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Traditional Physical Therapy
Arm Type
Active Comparator
Arm Description
Up to 20 sessions of traditional physical therapy.
Arm Title
AposTherapy
Arm Type
Experimental
Arm Description
Treatment with at home AposTherapy with daily use of the shoe.
Intervention Type
Device
Intervention Name(s)
AposTherapy
Intervention Description
AposTherapy® is a home-based exercise program utilizing footwear that causes exercise with normal daily activity
Intervention Type
Other
Intervention Name(s)
Traditional Physical Therapy
Intervention Description
Up to 20 sessions of traditional physical therapy
Primary Outcome Measure Information:
Title
Function
Description
Improvement in back pain measured and assessed with the Oswestry Disability Index (ODI).
Time Frame
1 Year
Secondary Outcome Measure Information:
Title
PROMIS (Patient-Reported Outcomes Measurement Information System) Pain Interference and Physical Function
Description
Pain and Function measured through PROMIS short forms
Time Frame
1 year
Title
Pain medication consumption
Description
medication consumption
Time Frame
1 year
Title
Quality of life survey
Description
Quality of life assessed with Short Form Health Survey questionnaire
Time Frame
1 year
Title
Gait assessment
Description
objective analysis of patients' gait assessed with a pressure mat to demonstrate stride length, velocity, and symmetry.
Time Frame
1 year
Title
6-min walk test
Description
objective assessment using maximum distance comfortably walked in 6 minutes on a 100 foot closed course
Time Frame
1 year
Title
Dynamic balance
Description
Measured by Berg balance test assessed with a questionnaire
Time Frame
1 year
Title
Static balance
Description
functional reach test assessed by physically testing the patient with a standardized set of instructions
Time Frame
1 year
Title
Blood pressure
Description
Change in blood pressure , physiological parameter
Time Frame
1 year
Title
resting heart rate
Description
change in resting heart rate , physiological parameter
Time Frame
1 year
Title
Overall activity
Description
overall activity measured as daily steps, through wristband devices
Time Frame
1 year
Title
sleep patterns
Description
Total sleep time measured in minutes through wristband activity monitor (FitBit) measured over one week
Time Frame
1 year
Title
Visual Analog Scale (VAS) for pain measurement
Description
questionnaire
Time Frame
1 year
Title
Medication Consumption
Description
Track increase or decrease in Medication consumption- assessed through patient interview and patent report
Time Frame
1 year
Title
Medication Costs
Description
Calculate monetary savings in Medication Costs- assessed through patient interview and prevailing market cost information
Time Frame
1 year
Title
Hospitalization utilizations
Description
Calculate the increase/decrease in hospital facility utilization - assessed with patient interview and health records.
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
•Patients suffering from symptomatic axial lower back pain for at least 24 weeks.
Patients with VAS pain score of ≥3cm (measured at baseline).
Males and females between the ages of 30-85.
17<BMI<40
Ambulatory and active patients that can participate in a rehabilitation program that includes daily walking
Stable medicine regimen (no recent changes to their pain medication within a month)
Able to walk at least 50 meters and scored positive on the STEADI test (Supp. 1)
Able to understand, read and sign the informed consent form
English or Spanish speaking
Exclusion Criteria:
•Patients suffering from active inflammatory joint disease.
Patients with diagnosis of neuromuscular disease.
Patients with more than 3 falls in the last 52 weeks, OR any balance related fall with an injury in the last 52 weeks.
Patients exhibiting a lack of physical or mental ability to perform or comply with the study procedure.
Patients with a history of pathological osteoporotic fracture
Patients with referred pain consistent with radicular etiology
Patients with generalized body pain (both upper and lower extremities).
No spine surgery within 24 weeks.
No image guided lumbar intervention in the past 8 weeks.
No major cardiovascular comorbidities (able to enroll in an active exercise program)
Patient started on lipid lowering medication in last 12 weeks
Any change in blood pressure medications
No recent physical therapy for the back. (within the last 12 weeks)
No active heart disease (ischemia or heart failure admissions within 24 weeks) and no active COPD (exacerbation within 24 weeks)
No active malignancies on ongoing treatment
Patient with neurological gait pattern.
Patient requiring assistive device during gait analysis.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Matthew N Bartels, MD, MPH
Organizational Affiliation
Montefiore Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Montefiore Medical Center
City
Bronx
State/Province
New York
ZIP/Postal Code
10467
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
19204216
Citation
Freburger JK, Holmes GM, Agans RP, Jackman AM, Darter JD, Wallace AS, Castel LD, Kalsbeek WD, Carey TS. The rising prevalence of chronic low back pain. Arch Intern Med. 2009 Feb 9;169(3):251-8. doi: 10.1001/archinternmed.2008.543.
Results Reference
background
PubMed Identifier
26487293
Citation
Meucci RD, Fassa AG, Faria NM. Prevalence of chronic low back pain: systematic review. Rev Saude Publica. 2015;49:1. doi: 10.1590/S0034-8910.2015049005874. Epub 2015 Oct 20.
Results Reference
background
PubMed Identifier
14710506
Citation
Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646-56. Epub 2003 Nov 14.
Results Reference
background
PubMed Identifier
15867409
Citation
Hayden JA, van Tulder MW, Malmivaara AV, Koes BW. Meta-analysis: exercise therapy for nonspecific low back pain. Ann Intern Med. 2005 May 3;142(9):765-75. doi: 10.7326/0003-4819-142-9-200505030-00013.
Results Reference
background
PubMed Identifier
17476489
Citation
Tsao H, Hodges PW. Immediate changes in feedforward postural adjustments following voluntary motor training. Exp Brain Res. 2007 Aug;181(4):537-46. doi: 10.1007/s00221-007-0950-z. Epub 2007 May 3.
Results Reference
background
PubMed Identifier
11389408
Citation
Hides JA, Jull GA, Richardson CA. Long-term effects of specific stabilizing exercises for first-episode low back pain. Spine (Phila Pa 1976). 2001 Jun 1;26(11):E243-8. doi: 10.1097/00007632-200106010-00004.
Results Reference
background
PubMed Identifier
3157094
Citation
Keefe FJ, Hill RW. An objective approach to quantifying pain behavior and gait patterns in low back pain patients. Pain. 1985 Feb;21(2):153-161. doi: 10.1016/0304-3959(85)90285-4.
Results Reference
background
Available IPD and Supporting Information:
Available IPD/Information Type
Book
Available IPD/Information URL
https://www.amazon.com/Prescription-Drug-Abuse-Epidemic-Understanding/dp/1886039224
Available IPD/Information Identifier
ISBN-10: 1886039224
Available IPD/Information Type
NAtional statistical Report
Available IPD/Information URL
https://www.bls.gov/news.release/pdf/osh2.pdf
Available IPD/Information Comments
year 2015
Learn more about this trial
The Effect of AposTherapy on Pain and Function in a Non Specific Low Back Pain
We'll reach out to this number within 24 hrs